Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.InteRNA receives EUR1.3m Innovation Credit from Dutch government
The company said that the purpose of the Innovation Credit is to reduce the financial risk for entrepreneurs and, as such, repayment of the credit, contributing 35% of
The company said that the purpose of the Innovation Credit is to reduce the financial risk for entrepreneurs and, as such, repayment of the credit, contributing 35% of
Elder Pharma has posted a net profit of INR135.38m for the second quarter 2010, compared to net profit of INR84.91m for the comparable period in 2009. For the
Orazol is a tablet formulation of zoledronic acid, made possible by Merrion’s proprietary Gipet technology, for which there are issued US Orazol patents to 2027. Merrion said that
Lpath said that the first patent (US 7,829,674) contains claims covering the composition of matter for its anti-Sphingosine-1-Phosphate (S1P) antibody, sonepcizumab, the active component in Lpath’s two lead
Unilife and Independent Medical (IMCO) have entered into a preferred, non-exclusive marketing program for the sale of Unitract 1mL syringes to US healthcare facilities. Unilife considers IMCO to
Amakem focuses on making drugs safer by limiting or avoiding systemic exposure, thereby reducing side effects caused in non target organs. Amakem CSO Dirk Leysen said that they
Merck Serono said that the marketing authorisations enabling commercial sales in the individual countries are expected over the next several months. Saizen solution for injection is a liquid
Importantly, rates of bleeding were similar to warfarin, and bleeding events most concerning to physicians and patients, including intracranial hemorrhage, critical organ bleed, and bleeding-related death, were significantly
The Food Standards Agency has issued a Product Withdrawal Information Notice in this regard. The product batches produced before November 2010 that are being withdrawn from sale include
3SBio has posted a net income of $3.94m for the third quarter 2010, or $0.03 per diluted share, compared to net income of $3.35m, or $0.02 per diluted